openPR Logo
Press release

Investigation announced for Long-Term Investors in BELLUS Health Inc. (NASDAQ: BLU)

06-10-2021 09:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in BELLUS Health Inc. (NASDAQ: BLU) shares.

An investigation on behalf of current long term investors in BELLUS Health Inc. (NASDAQ: BLU) shares.

An investigation on behalf of current long-term investors in shares of BELLUS Health Inc. (NASDAQ: BLU) concerning potential breaches of fiduciary duties by certain directors and officers of BELLUS Health Inc. was announced.

Investors who are current long term investors in BELLUS Health Inc. (NASDAQ: BLU) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: BLU stocks follows a lawsuit filed against BELLUS Health Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: BLU stocks, concerns whether certain BELLUS Health directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose information that resulted in a scheme that deceived the investing public regarding BELLUS Health Inc. 's business, operations, drug products, drug product development, competition, and present and future business prospects, that facilitated the Company's September 2019 public offering ("Offering"), that created artificial demand for the BELLUS Health Inc. common shares sold in the Offering, that enabled the Company to receive approximately $70 million in net proceeds from the sale of BELLUS Health Inc. common stock in the Offering, and that caused purchases of BELLUS Health Inc. publicly traded common stock at artificially inflated prices.

Those who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in BELLUS Health Inc. (NASDAQ: BLU) here

News-ID: 2302917 • Views: 331

More Releases from Shareholders Foundation

Lawsuit filed for Investors in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: A …
An investor, who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), filed a lawsuit over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc. Investors who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 9, 2021. NASDAQ: ACRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Redwood City, CA based
Deadline in Lawsuit for Investors in shares of Peloton Interactive, Inc. (NASDAQ …
A deadline is coming up on June 28, 2021 in the lawsuit filed for certain investors of Peloton Interactive, Inc. (NASDAQ: PTON) over alleged securities laws violations by Peloton Interactive, Inc. Investors who purchased shares of Peloton Interactive, Inc. (NASDAQ: PTON) have certain options and there are strict and short deadlines running. Deadline: June 28, 2021NASDAQ: PTON stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According
Investors in shares of Oscar Health, Inc. (NYSE: OSCR) are encouraged to contact …
An investigation on behalf of investors of Oscar Health, Inc. (NYSE: OSCR) shares over potential securities laws violations by Oscar Health, Inc. and certain of its directors and officers in connection with certain financial statements was announced. Investors who purchased shares of Oscar Health, Inc. (NYSE: OSCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on
Investigation announced for Investors in. NYSE: RKT shares over possible Wrongdo …
An investigation on behalf of investors in shares of Rocket Companies, Inc. (NYSE: RKT) was announced over potential breaches of fiduciary duties by certain officers and directors at Rocket Companies, Inc. Investors who purchased shares of Rocket Companies, Inc. (NYSE: RKT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Rocket Companies, Inc. directors breached

All 5 Releases


More Releases for BELLUS

Deadline on May 17th coming up in Lawsuit for Investors in BELLUS Health Inc. (N …
A deadline is coming up on May 17, 2021 in the lawsuit filed for certain investors of BELLUS Health Inc. (NASDAQ: BLU) over alleged securities laws violations by BELLUS Health Inc. Investors who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and there are strict and short deadlines running. Deadline: May 17, 2021. NASDAQ: BLU stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for Investors in shares of BELLUS Health Inc. (NASDAQ: BLU)
An investor, who purchased shares of BELLUS Health Inc. (NASDAQ: BLU), filed a lawsuit over alleged violations of Federal Securities Laws by BELLUS Health Inc. Investors who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and for certain investors are short and strict deadlines running. Deadline: May 17, 2021. NASDAQ: BLU investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Canada based BELLUS Health
Sarcoidosis Drug Market is expected to see growth rate of CAGR 4.1% By 2027 | Re …
The market study on the Sarcoidosis Drug Market published by Data bridge Market Research exhibits the important aspects that are estimated to shape the growth of the global Sarcoidosis Drug market over the forecast period (2027). The report efficiently gathers, analyzes and interprets information about a market, about a product or service to be offered for sale in that market. The market for Sarcoidosis Drug is growing with a significant
Global Sarcoidosis Drug Market (COVID - 19 Updates) 2020 to See Stunning Growth …
This Global Sarcoidosis Drug Market report gives idea to clients about the market drivers and restraints extracted from SWOT analysis and also provides all the CAGR projections for the historic year 2018, base year 2019 and forecast period of 2020-2025. With this, businesses can visualize the landscape about how the market is going to perform in the forecast years by gaining details on market definition, classifications, applications, and engagements. A
Sarcoidosis Drug Market : By Relief therapeutics holding SA, Firststring researc …
Sarcoidosis Drug Market Report examines the competitive scenario and gives all major players market share based on production capacity, sales, revenues, geographical presence and other important factors. The report includes a detailed description, a competitive scenario, a wide range of market leaders and business strategies adopted by competitors together with their SWOT analysis. It also provides explicit information about fusions, acquisitions, joint ventures and other important market activities in recent years.
RF Microneedling Market Outlook 2020: Details Analysis by top key companies like …
The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries